Please try to get your facts straight
"HAHA...you don't have any idea how big emerging markets segment is. Also, never said 7 bil multi billion."
Hmm, perhaps I misunderstood "he has a 7 billion dollar budget in emerging markets." Any one can reread that assertion from yesterday by viewing this post. At 06/26/17 07:59:13 AM in post 38789. (Sorry, a direct link resulted in a message saying: Ihub was having problems.)
"But you go right ahead and keep reading Linked In profiles and obscure PFE bio's."
False assumption. My primary source is Frank's, full 3 page resume, from February of of 2017, which I obtained from a friend. It's not a sanitized Pfizer bio. The first sentence in that resume is: "Senior Director/Team Leader Finance, Emerging Markets and Transition Sites 2012-Present Responsible for financially supporting over One Billion USD of manufacturing product cost spanning across 35 manufacturing plants globally throughout Emerging Markets."
Note that Frank says he's a "Team Leader" and that he is "Responsible for financially supporting ...". He's a high-level staff finance guy. He's done well. But he does not control a $7 billion dollar emerging markets budget. I suspect he is a trusted and valued advisor, but don't personally know.
Please don't pursue this line further. I can post Frank's full resume, which was publicly published on the web. It would clarify his real role at Pfizer, in spite of your hype. I have no desire to drag Frank through the mud. I suspect, you don't either.
Your choice. Game, set, match.
